Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 55154-0197

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 55154-0197). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

75mg Bag Label (7588ffdc 034d 4baf 9889 9a0ded265be5 00)

Label for Venlafaxine Hydrochloride Extended-Release Capsules USP 75 mg, package contains 10 capsules. The label includes storage instructions, dosage details, and a warning that the package is not child resistant. It indicates distribution by Cardinal Health and packaging by Major Pharmaceuticals, made in India. The NDC on the label is 55154-0197.*

FDA Label Image

Figure (Venlafaxine Fig1)

A pharmacokinetic fold change chart for venlafaxine showing changes in Cmax and AUC across special populations such as hepatic impairment, renal impairment, CYP2D6 polymorphism, age over 60, and gender. The x-axis represents change relative to reference value, with data points indicating fold changes and 90% confidence intervals for each condition.*

FDA Label Image

Figure (Venlafaxine Fig2)

A forest plot chart depicting the fold change and 90% confidence intervals of pharmacokinetic (PK) parameters Cmax and AUC for venlafaxine in the presence of various interacting drugs, including ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium. The chart shows fold changes relative to the reference value with PK parameters measured for venlafaxine analyte and oral dose volume (ODV).*

FDA Label Image

Figure (Venlafaxine Fig3)

A forest plot chart illustrating fold changes and 90% confidence intervals for various analytes related to interacting drugs including ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, toltubamide, and lithium. The x-axis shows change relative to a reference value, with markers indicating Cmax and AUC pharmacokinetic parameters.*

FDA Label Image

Chemical Structure (Venlafaxine Str)

Chemical structure of venlafaxine hydrochloride showing its molecular arrangement with a cyclohexanol group, methoxy-substituted aromatic ring, and dimethylaminoethyl side chain.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.